Literature DB >> 9632752

AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells.

S M Jacobs-Helber1, A Wickrema, M J Birrer, S T Sawyer.   

Abstract

The transcription factor AP1 has been implicated in the induction of apoptosis in cells in response to stress factors and growth factor withdrawal. We report here that AP1 is necessary for the induction of apoptosis following hormone withdrawal in the erythropoietin (EPO)-dependent erythroid cell line HCD57. AP1 DNA binding activity increased upon withdrawal of HCD57 cells from EPO. A dominant negative AP1 mutant rendered these cells resistant to apoptosis induced by EPO withdrawal and blocked the downregulation of Bcl-XL. JunB is a major binding protein in the AP1 complex observed upon EPO withdrawal; JunB but not c-Jun was present in the AP1 complex 3 h after EPO withdrawal in HCD57 cells, with a concurrent increase in junB message and protein. Furthermore, analysis of AP1 DNA binding activity in an apoptosis-resistant subclone of HCD57 revealed a lack of induction in AP1 DNA binding activity and no change in junB mRNA levels upon EPO withdrawal. In addition, we determined that c-Jun and AP1 activities correlated with EPO-induced proliferation and/or protection from apoptosis. AP1 DNA binding activity increased over the first 3 h following EPO stimulation of HCD57 cells, and suppression of AP1 activity partially inhibited EPO-induced proliferation. c-Jun but not JunB was present in the AP1 complex 3 h after EPO addition. These results implicate AP1 in the regulation of proliferation and survival of erythroid cells and suggest that different AP1 factors may play distinct roles in both triggering apoptosis (JunB) and protecting erythroid cells from apoptosis (c-Jun).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632752      PMCID: PMC108952          DOI: 10.1128/MCB.18.7.3699

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

Review 1.  The molecular mechanism of erythropoietin action.

Authors:  M J Koury; M C Bondurant
Journal:  Eur J Biochem       Date:  1992-12-15

2.  JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers.

Authors:  T Deng; M Karin
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

3.  Promoter-specific trans-activation and inhibition mediated by JunB.

Authors:  J C Hsu; D E Cressman; R Taub
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

4.  Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor.

Authors:  J E Damen; A L Mui; L Puil; T Pawson; G Krystal
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

5.  Mechanism of action of a dominant-negative mutant of c-Jun.

Authors:  P H Brown; T K Chen; M J Birrer
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

6.  Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production.

Authors:  L L Kelley; M J Koury; M C Bondurant; S T Koury; S T Sawyer; A Wickrema
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

7.  Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein.

Authors:  J E Damen; L Liu; R L Cutler; G Krystal
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

8.  Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain.

Authors:  T C He; H Zhuang; N Jiang; M D Waterfield; D M Wojchowski
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

9.  Suppression of oncogene-induced transformation by a deletion mutant of c-jun.

Authors:  P H Brown; R Alani; L H Preis; E Szabo; M J Birrer
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

10.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

View more
  26 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Current methods for detecting antibodies against erythropoietin and other recombinant proteins.

Authors:  Robin Thorpe; Steven J Swanson
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

4.  Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid.

Authors:  Steve J Morrissy; Haipeng Sun; Jack Zhang; Joshua Strom; Qin M Chen
Journal:  J Biochem Mol Toxicol       Date:  2016-02-25       Impact factor: 3.642

5.  Isolation and characterization of goat retinal microvascular endothelial cells.

Authors:  Ravinarayanan Haribalaganesh; Elayappan Banumathi; Sardarpasha Sheikpranbabu; Venkataraman Deepak; Namagiri Sirishkumar; Sangiliyandi Gurunathan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-07       Impact factor: 2.416

6.  Anti-tumor activity of curcumin against androgen-independent prostate cancer cells via inhibition of NF-κB and AP-1 pathway in vitro.

Authors:  Shuanglin Liu; Zhihua Wang; Zhiquan Hu; Xing Zeng; Youyuan Li; Yaowu Su; Chuanhua Zhang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

7.  Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Delores Thompson; Takashi Yugawa; Sandra Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.

Authors:  Erik C Mazur; Yasmin M Vasquez; Xilong Li; Ramakrishna Kommagani; Lichun Jiang; Rui Chen; Rainer B Lanz; Ertug Kovanci; William E Gibbons; Francesco J DeMayo
Journal:  Endocrinology       Date:  2015-03-17       Impact factor: 4.736

9.  Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats.

Authors:  Taranjeet Kaur; Harpal Singh; Rachana Mishra; Shaffi Manchanda; Muskan Gupta; Vedangana Saini; Anuradha Sharma; Gurcharan Kaur
Journal:  Mol Cell Biochem       Date:  2016-12-21       Impact factor: 3.396

10.  Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments.

Authors:  Shaffi Manchanda; Harpal Singh; Taranjeet Kaur; Gurcharan Kaur
Journal:  Mol Cell Biochem       Date:  2018-03-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.